[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

WSJ: NEJM Misses Vioxx Warning Signs

To: <liblicense-l@lists.yale.edu>
Subject: WSJ: NEJM Misses Vioxx Warning Signs
From: "Masterson, Michele" <Michele_Masterson@simbanet.com>
Date: Mon, 15 May 2006 21:02:33 EDT
Reply-to: liblicense-l@lists.yale.edu
Sender: owner-liblicense-l@lists.yale.edu

I am writing an article an article concerning today's story in 
the WSJ, "Bitter Pill: How the New England Journal Missed Warning 
Signs on Vioxx." I would like to get input/reactions from STM 
societies/publishers as soon as possible. Please feel free to 
e-mail me privately if you do not want your posts stated 
publicly. I am deadline, so I would appreciate responses as soon 
as possible, thanks.

The article reports some very troubling news, alleging that the 
"medical weekly waited years to report flaws in article that 
praised pain drug." In a summary, a blog on the Pharma Marketing 
News Web site stated:  We were hoodwinked!

http://pharmamkting.blogspot.com/2006/05/we-were-hoodwinked.html

michele_masterson@simbanet.com
Michele Masterson
Editor/Analyst
Simba Information
www.simbanet.com

Prev by Date: RE: Does BMC's business model conflict with Editorial Independence?
Next by Date: RE: Does BMC's business model conflict with Editorial Independence?
Previous by thread: The Goodman-Banks thread
Next by thread: Re: WSJ: NEJM Misses Vioxx Warning Signs
Index(es):
- Date
- Thread